{"id":56146,"date":"2023-04-24T17:04:58","date_gmt":"2023-04-24T15:04:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/"},"modified":"2023-04-24T17:04:58","modified_gmt":"2023-04-24T15:04:58","slug":"valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/","title":{"rendered":"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir"},"content":{"rendered":"
\n

LIBERTYVILLE, Ill.–(BUSINESS WIRE)–Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has been named President and CEO, also effective July 2023.<\/p>\n

<\/a>
<\/a><\/p>\n

\nMelnik joined Valent BioSciences in 2013 as Chief Operating Officer and was promoted to his current position in 2022. During his 10-year tenure at Valent BioSciences, Melnik oversaw significant company growth through business acquisitions, including Mycorrhizal Applications, Kyowa Hakko Bio Co., Ltd., the Canadian forestry business of AEF Global Inc., and FBSciences Holdings, Inc.<\/p>\n

\nOther business milestones that he directed include the construction of Valent BioSciences\u2019 biorational manufacturing facility in Osage, Iowa, as well as the opening of the Biorational Research Center and Global Headquarters in Libertyville, Illinois. Some of the key product launches over this period include VectoPrime\u00ae<\/sup> Biological Larvicide, LEAP\u00ae<\/sup> Bacterial Disease Management Biological Insecticide, AVEO\u2122 EZ Nematicide, InGrain\u2122 Plant Growth Regulator, and Accede\u00ae<\/sup> Plant Growth Regulator.<\/p>\n

\n\u201cI want to thank Ted for his many invaluable contributions to the organization during the past 10 years,\u201d said Nobuaki Mito, Representative Director and Senior Managing Executive Officer of Sumitomo Chemical Co., Ltd. \u201cNot only has he elevated Valent BioSciences\u2019 global industry leadership position, but he has left his imprint on the company in numerous areas \u2013 from acquisitions, investments in new facilities, and the launch of new products to the many different people he taught and mentored. Although Ted will be greatly missed, he has established a strong business foundation for continued growth and success.\u201d<\/p>\n

\nIn his new role as President and CEO of the company, Mir will be responsible for overseeing the entire spectrum of global activities at Valent BioSciences. He has extensive experience in sales, marketing, operations, and business development roles with several major global crop protection companies.<\/p>\n

\nMir joined Valent BioSciences in 2012 as Vice President of Global Marketing and Business Management, where he was responsible for leading the company\u2019s global marketing and commercial activities. In 2016, he moved to Sumitomo Chemical\u2019s AgroSolutions Division International (ASDI) for an overseas assignment. During his tenure there, he was Head of AgroSolutions Division International (Asia Pacific) and General Manager Sumitomo Chemical Asia (SCA). He returned to the U.S. in 2019 to serve as Chief Operating Officer of Valent BioSciences subsidiary Pace International LLC in Wapato, Washington. In early 2021, he began leading the Global Sustainable Solutions Business Unit (SSBU) team in partnership with Sumitomo Chemical affiliates around the world and also assumed the new position of Chief Commercial Officer for Valent BioSciences. He was promoted to Executive Vice President and Chief Operating Officer in 2022.<\/p>\n

\nMir holds an undergraduate Veterinary Sciences degree from the University of Veterinary and Animal Sciences and earned his master\u2019s degree in Business Administration from Lahore University of Management Sciences, Pakistan.<\/p>\n

\n\u201cSalman\u2019s elevation to President and CEO will provide a seamless transition for our business, employees, and customers,\u201d said Mito. \u201cI am confident that he will continue discovering exciting new business opportunities and guide Valent BioSciences to even more successes as a global leader in biorational products in the years ahead. I appreciate all of Salman\u2019s past accomplishments and congratulate him on his well-earned new role.\u201d<\/p>\n

\nAbout Valent BioSciences LLC<\/b><\/p>\n

\nHeadquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd. Valent BioSciences is a worldwide leader in the development, manufacturing, and commercialization of biorational products and technologies used in the agriculture, public health, and forest health markets. The company has more than 60 years of experience bringing biorational products to market in 95 countries around the world and is ISO 9001 Certified. Valent BioSciences is also the parent company of Pace International LLC, a global leader in postharvest coatings, sanitizers, and postharvest disease management products, as well as Mycorrhizal Applications LLC, the world\u2019s leading supplier of arbuscular mycorrhizal fungi-based products. For additional information, visit the company\u2019s website at www.valentbiosciences.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nJohn Mandel
\n
Valent BioSciences LLC
\n
847-968-4728
\n
Email: john.mandel@valentbiosciences.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LIBERTYVILLE, Ill.–(BUSINESS WIRE)–Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56146","6":"format-standard","7":"category-industry"},"yoast_head":"\nValent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LIBERTYVILLE, Ill.–(BUSINESS WIRE)–Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T15:04:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230424005639\/en\/1772101\/21\/Ted_Melnik.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir\",\"datePublished\":\"2023-04-24T15:04:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/\"},\"wordCount\":697,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005639\\\/en\\\/1772101\\\/21\\\/Ted_Melnik.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/\",\"name\":\"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005639\\\/en\\\/1772101\\\/21\\\/Ted_Melnik.jpg\",\"datePublished\":\"2023-04-24T15:04:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005639\\\/en\\\/1772101\\\/21\\\/Ted_Melnik.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005639\\\/en\\\/1772101\\\/21\\\/Ted_Melnik.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/","og_locale":"en_US","og_type":"article","og_title":"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir - Pharma Trend","og_description":"LIBERTYVILLE, Ill.–(BUSINESS WIRE)–Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-24T15:04:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230424005639\/en\/1772101\/21\/Ted_Melnik.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir","datePublished":"2023-04-24T15:04:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/"},"wordCount":697,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230424005639\/en\/1772101\/21\/Ted_Melnik.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/","url":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/","name":"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230424005639\/en\/1772101\/21\/Ted_Melnik.jpg","datePublished":"2023-04-24T15:04:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230424005639\/en\/1772101\/21\/Ted_Melnik.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230424005639\/en\/1772101\/21\/Ted_Melnik.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-announces-the-retirement-of-ted-melnik-and-promotion-of-salman-mir\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Valent BioSciences Announces the Retirement of Ted Melnik and Promotion of Salman Mir"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56146"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56146\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}